Found: 17
Select item for more details and to access through your institution.
Fidaxomicin-Associated Hypersensitivity Reactions: Report of a Morbilliform Drug Eruption.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Efficacy of Fecal Microbiota, Live-jslm (REBYOTA®), Among Patients Exposed to Non–Clostridioides difficile Infection Antibiotics: Post Hoc Subgroup Analysis of a Phase 2 Open-Label Study.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 7, p. 1, doi. 10.1093/ofid/ofae341
- By:
- Publication type:
- Article
Colistin Nephrotoxicity: Meta-Analysis of Randomized Controlled Trials.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 2, p. 1, doi. 10.1093/ofid/ofab026
- By:
- Publication type:
- Article
756. Impact of Infectious Diseases Pharmacists as Part of an Interdisciplinary OPAT Team Managing Vancomycin.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S337, doi. 10.1093/ofid/ofz360.824
- By:
- Publication type:
- Article
Use of Oral Tetracyclines in the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia: A Literature Review on the Often-Overlooked Antibiotic Class.
- Published in:
- Antibiotics (2079-6382), 2020, v. 9, n. 12, p. 905, doi. 10.3390/antibiotics9120905
- By:
- Publication type:
- Article
Relationship between day 1 and day 2 Vancomycin area under the curve values and emergence of heterogeneous Vancomycin-intermediate Staphylococcus aureus (hVISA) by Etest® macromethod among patients with MRSA bloodstream infections: a pilot study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Effect of prior receipt of antibiotics on the pathogen distribution and antibiotic resistance profile of key Gram-negative pathogens among patients with hospital-onset urinary tract infections.
- Published in:
- BMC Infectious Diseases, 2017, v. 17, p. 1, doi. 10.1186/s12879-017-2270-7
- By:
- Publication type:
- Article
Gut microbiome health and dysbiosis: A clinical primer.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 11, p. 849, doi. 10.1002/phar.2731
- By:
- Publication type:
- Article
Use of oral tetracyclines in the treatment of adult outpatients with skin and skin structure infections: Focus on doxycycline, minocycline, and omadacycline.
- Published in:
- Pharmacotherapy, 2021, v. 41, n. 11, p. 915, doi. 10.1002/phar.2625
- By:
- Publication type:
- Article
Approach to the Treatment of Patients with Serious Multidrug‐Resistant Pseudomonas aeruginosa Infections.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 9, p. 952, doi. 10.1002/phar.2449
- By:
- Publication type:
- Article
Suboptimal Clinical Response Rates with Newer Antibiotics Among Patients with Moderate Renal Impairment: Review of the Literature and Potential Pharmacokinetic and Pharmacodynamic Considerations for Observed Findings.
- Published in:
- Pharmacotherapy, 2018, v. 38, n. 12, p. 1205, doi. 10.1002/phar.2184
- By:
- Publication type:
- Article
Fluoroquinolone-Associated Tendinopathy: Does Levofloxacin Pose the Greatest Risk?
- Published in:
- Pharmacotherapy, 2016, v. 36, n. 6, p. 679, doi. 10.1002/phar.1761
- By:
- Publication type:
- Article
Baseline procalcitonin as a predictor of bacterial infection and clinical outcomes in COVID-19: A case-control study.
- Published in:
- PLoS ONE, 2022, v. 17, n. 1, p. 1, doi. 10.1371/journal.pone.0262342
- By:
- Publication type:
- Article
Therapeutic drug monitoring of flucytosine in a cardiac transplant patient receiving continuous veno‐venous hemofiltration and intermittent hemodialysis: A case report.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Remdesivir use and outcomes during the FDA COVID-19 emergency use authorization period.
- Published in:
- Therapeutic Advances in Infectious Disease, 2021, v. 8, p. 1, doi. 10.1177/20499361211046669
- By:
- Publication type:
- Article
Optimal treatment of MSSA bacteraemias: a meta-analysis of cefazolin versus antistaphylococcal penicillins.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Characterization of the haematological profile of 21 days of tedizolid in healthy subjects.
- Published in:
- 2016
- By:
- Publication type:
- journal article